ThomasMPisanskyMD
Radiation Oncology • Rochester, MNBreast Cancer, Urologic Cancer
Professor, Oncology, Mayo Medical School
Dr. Pisansky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1984 - 1987
Hennepin HealthcareResidency, Internal Medicine, 1980 - 1984
University of Minnesota Medical SchoolClass of 1980
Certifications & Licensure
AZ State Medical License 1988 - Present
MN State Medical License 1982 - 2024
FL State Medical License 1987 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus Start of enrollment: 1995 Jun 01
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Start of enrollment: 2002 Feb 01
- Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.Mak, K., Scannell Bryan, M., Dignam, J., Shipley, W., Lin, Y., Peters, C., Gore, E., Rosenthal, S., Zeitzer, K., D'Souza, D., Horwitz, E., Pisansky, T., Maier, J., Cha...> ;European Urology Focus. 2024 Feb 1
- Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy: Brachytherapy as Dose Escalation for Localized Prostate Cancer.Thomas M Pisansky> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Apr 1
- Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Sandy DeVries, Emmalyn Chen, Edward M Schaeffer, Todd M Morgan, Yilun Sun, Amirata Ghorba...> ;NPJ Digital Medicine. 2023 Feb 22
- Join now to see all
Journal Articles
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
- Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological FeaturesRahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA
Press Mentions
Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021- Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline (2013, Amended 2018 & 2019)June 4th, 2019
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
